Cargando…

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update

The goal of this review is to present the similarities and differences among the latest guidelines for noninvasive diagnosis of hepatocellular carcinoma (HCC) of American Association for the Study of Liver Disease (AASLD), European Association for the Study of the Liver (EASL), Liver Imaging Reporti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae-Hyung, Kim, So Yeon, Tang, An, Lee, Jeong Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759428/ https://www.ncbi.nlm.nih.gov/pubmed/30759967 http://dx.doi.org/10.3350/cmh.2018.0090

Ejemplares similares

Emerging Role of Hepatobiliary Magnetic Resonance Contrast Media and Contrast-Enhanced Ultrasound for Noninvasive Diagnosis of Hepatocellular Carcinoma: Emphasis on Recent Updates in Major Guidelines
por: Kim, Tae-Hyung, et al.
Publicado: (2019)

Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging
por: Lee, Sunyoung, et al.
Publicado: (2020)

Noninvasive diagnosis of hepatocellular carcinoma
por: Kim, Byung Seok
Publicado: (2012)

Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline
por: Kang, Hyo-Jin, et al.
Publicado: (2023)

Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues
por: Yoon, Jeong Hee, et al.
Publicado: (2016)

Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis
por: Jiang, Han-Yu, et al.
Publicado: (2018)

Validation of the Korean Liver Cancer Association-National Cancer Center 2018 Criteria for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using Magnetic Resonance Imaging
por: Lee, Sunyoung, et al.
Publicado: (2020)

Erratum: Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues
por: Yoon, Jeong Hee, et al.
Publicado: (2016)

Update of Guidelines for Laboratory Diagnosis of COVID-19 in Korea
por: Hong, Ki Ho, et al.
Publicado: (2022)

Molecular Noninvasive Diagnosis of Hepatocellular Carcinoma Using Microsatellite Instability
por: Mamdouh, Samah, et al.
Publicado: (2021)

Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?
por: Kim, So Yeon
Publicado: (2020)

Noninvasive Fibrosis Marker Can Predict Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation
por: Chung, Hyun Ah, et al.
Publicado: (2016)

Updates on the Diagnosis and Management of Hepatocellular Carcinoma
por: Raees, Aimun, et al.
Publicado: (2021)

Gestational diabetes mellitus 2018 guidelines: An update
por: Mishra, Surabhi, et al.
Publicado: (2018)

Hepatocellular Carcinoma Arising in a Huge Hepatocellular Adenoma with Bone Marrow Metaplasia
por: Kang, Hyo Jeong, et al.
Publicado: (2018)

Noninvasive diagnostic criteria for hepatocellular carcinoma
por: Lee, Han Chu
Publicado: (2012)

The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension
por: Kim, Hack-Lyoung, et al.
Publicado: (2023)

Diagnostic Performance of 2018 KLCA-NCC Practice Guideline for Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI in Patients with Chronic Hepatitis B or Cirrhosis: Comparison with LI-RADS Version 2018
por: Lee, Sang Min, et al.
Publicado: (2021)

Noninvasive Diagnosis of Hepatocellular Carcinoma on Sonazoid-Enhanced US: Value of the Kupffer Phase
por: Takahashi, Hiroshi, et al.
Publicado: (2022)

Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
por: Chang, Young, et al.
Publicado: (2020)

Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2018)

Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018 (English version)
por: National Health Commission of the People’s Republic of China,
Publicado: (2019)

Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound
por: Park, Junghoan, et al.
Publicado: (2022)

2018 Guidelines for the management of dyslipidemia
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
por: Omata, Masao, et al.
Publicado: (2017)

Korean Asthma Guideline 2014: Summary of Major Updates to the Korean Asthma Guideline 2014
por: Kim, Deog Kyeom, et al.
Publicado: (2016)

2018 Korean Guideline of Atrial Fibrillation Management
por: Joung, Boyoung, et al.
Publicado: (2018)

Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2019)

Comparison of International Guidelines of Dermal Absorption Tests Used in Pesticides Exposure Assessment for Operators
por: So, Jaehwan, et al.
Publicado: (2014)

Chinese guidelines for diagnosis and treatment of renal cell carcinoma 2018 (English version)
Publicado: (2019)

Chinese guidelines for diagnosis and treatment of urothelial carcinoma of bladder 2018 (English version)
Publicado: (2019)

Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria
por: Yoon, Ja Kyung, et al.
Publicado: (2023)

Comparison of international guideline programs to evaluate and update the Dutch program for clinical guideline development in physical therapy
por: Van der Wees, Philip J, et al.
Publicado: (2007)

Role of ssDNA as a Noninvasive Indicator for the Diagnosis and Prognosis of Hepatocellular Carcinoma: An Exploratory Study
por: Zhao, Qi, et al.
Publicado: (2021)

Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
por: Cho, Yuri, et al.
Publicado: (2023)

2018 Guidelines for the Management of Dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

2018 Guidelines for the management of dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

Need for an Update for the Guideline for the Management of Mild Cognitive Impairment
por: Kim, Minji, et al.
Publicado: (2022)

Noninvasive Identification of Immune-Related Biomarkers in Hepatocellular Carcinoma
por: Li, Ling, et al.
Publicado: (2019)

A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights
por: Xie, Di-Yang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cjvali3u6sfo8fjd7v43n0a7te